Want to join the conversation?
$MSI 2Q15 Call: North America grew 5% marking its third consecutive quarter of growth and the overall business grew 2% when adjusting for FX. Operational execution continues to drive improved profitability and cash flow generation, as reflected in our double digit growth of EPS and double digit growth in free cash flow per share.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.